Changes to Havrix booster dose

Changes to the prescribing information for the Havrix Monodose hepatitis A vaccine mean that it is no longer necessary to restart the primary vaccination schedule if the booster is administered within five years of primary vaccination.

Although a booster dose is normally recommended between six to 12 months of primary vaccination, it has been shown that immunocompetent subjects given a booster up to five years after initial vaccination can show a satisfactory antibody response sufficient for persistent immunity.

Further information: GlaxoSmithKline, Stockley Park West, Uxbridge, Middlesex UB11 1BT. Tel: (0800) 221441.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases